Mitamura Takashi 三田村卓

Researcher Number	90625641
Other IDs
Affiliation (Current)	2025: 北海道大学, 大学病院, 講師
Affiliation (based on the past Project Information) *help	2024 – 2025: 北海道大学, 大学病院, 講師 2019 – 2021: 北海道大学, 大学病院, 助教
Review Section/Research Field	Principal Investigator Basic Section 50010:Tumor biology-related / Basic Section 56040:Obstetrics and gynecology-related Except Principal Investigator Basic Section 58010:Medical management and medical sociology-related
Keywords	Principal Investigator PDX / 薬剤耐性 / VEGF / 血管新生阻害療法 / 卵巣癌 / 血管新生阻害 / 前臨床試験 / CCR2阻害薬 / 併用療法 / CCR2 / ベバシズマブ / 血管新生阻害薬 / 卵巣がん … More Except Principal Investigator … More 均てん化 / 医療格差 / ICT / ゲノム医療 / 遠隔医療 Less

Tリンパ球におけるPRDM1遺伝子多型と抗腫瘍免疫機能との相関に関する基礎的研究Principal Investigator
- Principal Investigator
  
  三田村卓
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50010:Tumor biology-related
- Research Institution
  Hokkaido University
Identification of issues and solution strategies for the development of genomic medicine in remote areas lacking in medical resources
- Principal Investigator
  
  山田崇弘
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 58010:Medical management and medical sociology-related
- Research Institution
  Hokkaido University
Combination therapy with bevacizumab and CCR2 inhibitor for women with ovarian cancerPrincipal Investigator
- Principal Investigator
  
  Mitamura Takashi
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Hokkaido University

All 2021 2020 2019

All Journal Article Presentation

[Journal Article] The disease sites of female genital cancers of BRCA1/2-associated hereditary breast and ovarian cancer: a retrospective study.2021
- Author(s)
  Takashi Mitamura, Masayuki Sekine, Masami Arai, Yuka Shibata, Momoko Kato, Shiro Yokoyama, Hiroko Yamashita, Hidemichi Watari, Ichiro Yabe, Hiroyuki Nomura, Takayuki Enomoto, Seigo Nakamura and and the Registration Committee of the Japanese HBOC consortium
- Journal Title
  
  World Journal of Surgical Oncology.
  
  Volume: 19(1) Issue: 1 Pages: 36-36
- DOI
  10.1186/s12957-021-02151-3
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K09818
[Journal Article] 特集図解　分子メカニズムから理解する婦人科がんの薬物療法【総論】 Ⅰ　婦人科における抗悪性腫瘍薬の種類と特徴 4.トポイソメラーゼ阻害薬:イリノテカン,トポテカン,エトポシド2021
- Author(s)
  三田村卓
- Journal Title
  
  産婦人科の実際
  
  Volume: 70 Issue: 12 Pages: 1244-1249
- DOI
  10.18888/sp.0000001928
- ISSN
  0558-4728
- Year and Date
  2021-11-30
- Data Source
  KAKENHI-PROJECT-19K09818
[Journal Article] Clinical significance of comprehensive genomic profiling tests covered by public insurance in patients with advanced solid cancers in Hokkaido, Japan2021
- Author(s)
  Kikuchi Junko、Ohhara Yoshihito、Takada Kohichi、Kinoshita Ichiro
- Journal Title
  
  Japanese Journal of Clinical Oncology
  
  Volume: - Issue: 5 Pages: 753-761
- DOI
  10.1093/jjco/hyaa277
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08397, KAKENHI-PROJECT-20K07691, KAKENHI-PROJECT-19K09818
[Journal Article] 血管新生阻害薬の有効利用2019
- Author(s)
  三田村卓, 王磊, さいてんげつ, 渡利英道
- Journal Title
  
  BIO Clinica
  
  Volume: 34(10) Pages: 1020-1022
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K09818
[Presentation] がんゲノムプロファイリング検査で検出された生殖細胞系列変異を疑う所見の開示に関する検討2021
- Author(s)
  三田村卓
- Organizer
  第73回日本産科婦人科学会学術講演会
- Data Source
  KAKENHI-PROJECT-19K09818
[Presentation] 遺伝性乳癌卵巣癌症候群における卵巣・卵管・腹膜癌の臨床病理学的特徴に関する検討2021
- Author(s)
  三田村卓, 関根正幸, 新井正美, 柴田有花, 加藤ももこ, 横山士郎, 山下啓子, 渡利英道, 野村弘行, 榎本隆之, 中村清吾
- Organizer
  第63回日本婦人科腫瘍学会学術講演会
- Data Source
  KAKENHI-PROJECT-19K09818
[Presentation] 卵巣明細胞癌におけるKRAS変異と化学療法感受性の関連2021
- Author(s)
  朝野拓史, 畑中佳奈子, 遠藤大介, 山崎博之, 井平圭, 三田村卓, 金野陽輔, 加藤達矢, 小林範子, 武田真人, 工藤正尊, 畑中豊, 渡利英道
- Organizer
  第73回日本産科婦人科学会学術講演会
- Data Source
  KAKENHI-PROJECT-19K09818
[Presentation] Risk factors for lymph node metastasis of ovarian, fallopian tube and primary peritoneal cancer in hereditary breast and ovarian cancer syndrome.2020
- Author(s)
  Takashi Mitamura, Masayuki Sekine, Masami Arai, Shiro Yokoyama, Hiroko Yamashita, Hidemichi Watari, Ichiro Yabe, Hiroyuki Nomura, Takayuki Enomoto, and Seigo Nakamura
- Organizer
  ESGO State of the Art Conference 2020
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K09818
[Presentation] Induction of anti-VEGF therapy resistance by upregulated expression of MSMP2019
- Author(s)
  Takashi Mitamura, Yosuke Konno, Tatsuya Kato, Hiroshi Asano, Ayako Nozaki, Kei Ihira, Yukako Kobayashi, Risa Ando, Akira Oku, Hidemichi Watari
- Organizer
  ASGO (Asian Society of Gynecologic Oncology) 6th Biennial Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K09818

1. 渡利英道 (10344508)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
2. 畑中佳奈子 (10399834)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
3. 天野虎次 (20374514)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 畑中豊 (30589924)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
5. 山田崇弘 (20419948)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 松島理明 (10443938)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 蒔田芳男 (20271778)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. 柴田有花 (40963301)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 矢部一郎 (60372273)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. 高田弘一

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Mitamura Takashi 三田村 卓

Research Projects

Research Products

Co-Researchers

Tリンパ球におけるPRDM1遺伝子多型と抗腫瘍免疫機能との相関に関する基礎的研究Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Identification of issues and solution strategies for the development of genomic medicine in remote areas lacking in medical resources

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Combination therapy with bevacizumab and CCR2 inhibitor for women with ovarian cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] The disease sites of female genital cancers of BRCA1/2-associated hereditary breast and ovarian cancer: a retrospective study.2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] 特集 図解 分子メカニズムから理解する婦人科がんの薬物療法 【総論】 Ⅰ 婦人科における抗悪性腫瘍薬の種類と特徴 4.トポイソメラーゼ阻害薬:イリノテカン,トポテカン,エトポシド2021

Author(s)

Journal Title

DOI

ISSN

Year and Date

Data Source

[Journal Article] Clinical significance of comprehensive genomic profiling tests covered by public insurance in patients with advanced solid cancers in Hokkaido, Japan2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] 血管新生阻害薬の有効利用2019

Author(s)

Journal Title

Data Source

[Presentation] がんゲノムプロファイリング検査で検出された生殖細胞系列変異を疑う所見の開示に関する検討2021

Author(s)

Organizer

Data Source

[Presentation] 遺伝性乳癌卵巣癌症候群における卵巣・卵管・腹膜癌の臨床病理学的特徴に関する検討2021

Author(s)

Organizer

Data Source

[Presentation] 卵巣明細胞癌におけるKRAS変異と化学療法感受性の関連2021

Author(s)

Organizer

Data Source

[Presentation] Risk factors for lymph node metastasis of ovarian, fallopian tube and primary peritoneal cancer in hereditary breast and ovarian cancer syndrome.2020

Author(s)

Organizer

Data Source

[Presentation] Induction of anti-VEGF therapy resistance by upregulated expression of MSMP2019

Author(s)

Organizer

Data Source

Mitamura Takashi 三田村卓

[Journal Article] 特集図解　分子メカニズムから理解する婦人科がんの薬物療法【総論】 Ⅰ　婦人科における抗悪性腫瘍薬の種類と特徴 4.トポイソメラーゼ阻害薬:イリノテカン,トポテカン,エトポシド2021